Nosocomial bloodstream infections in HIV-infected patients: Attributable mortality and extension of hospital stay

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 5, 1998, Pages 490-497

  Tumbarello, Mario ^a   Tacconelli, Evelina ^a   Donati, Katleen De Gaetano ^a   Leone, Fiammetta ^a   Morace, Giulia ^a   Cauda, Roberto ^a   Ortona, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

AIDS; Attributable mortality; Nosocomial bloodstream infections; Prognostic indicators; Risk factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD DISEASE; CELLULAR IMMUNITY; FEMALE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032535182     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199812150-00008     Document Type: Article

References (44)

1. Platt R, Goldmann D, Hopkins CC. Epidemiology of nosocomial infections. In Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. Philadelphia: WB Saunders, 1992:96-106.
2. Edmond MB, Wenzel RP. Infection control, In Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:2572-9.
3. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality and contribution to total hospital deaths. Arch Intern Med 1995;155:1177-84.
4. Pittet D. Nosocomial bloodstream infections. In Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams & Wilkins, 1997:711-69.
5. Craven DE, Steger KA, Hirschorn LR. Nosocomial colonization and infection in persons infected with human immunodeficiency virus. Infect Control Hosp Epidemiol 1996;17:304-18.
6. Hirschorn LR, Steger KA, Craven DE. Nosocomial infection in adults infected with human immunodeficiency virus. In Mayhall CG, Baltimore MD, eds. Hospital epidemiology and infection control. Baltimore: Williams & Wilkins, 1995:593-610.
7. Selva J, Ninivaggi M, Toledo A, Forlenza S. Nosocomial infections in HIV infected patients in a large teaching hospital. Am J Infect Control 1993;21:103-7.
8. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P. Septicèmies communitaires et nosocomiales chez le patient infectée par le virus de l'immunodeficience humaine. Presse Med 1996;25: 746-50.
9. Zurlo JJ, Lane HC. Other bacterial infections. In De Vita VT Jr., Hellman S, Rosenberg SA, eds. AIDS: etiology, diagnosis, treatment and prevention. Philadelphia: Lippincott-Raven, 1997:259-66.
10. Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clin Rev 1991;5:61-79.
11. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995;31:123-31.
12. Gilks CF, Brindle RJ, Otieno LS, et al. Life threatening bacteremia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990;336:545-9.
13. Hickey MM, Shanson DC. Septicemia in patients with and without AIDS at Westminster Hospital, London. J Infect 1993;27:243-50.
14. Fife D, Crane GL, Bishburg E. Cumulative AIDS incidence and altered mortality from bacterial infections. AIDS Res Hum Retroviruses 1990;6:1203-8.
15. Centers for Disease Control and Prevention. Increase in national hospital discharge survey notes for bacteremia-United States 1979-1987. MMWR Morb Mortal Wkly Rep 1990;39:31-4.
16. Beuheza J, Beckelman R, Devine O, Cheverley F. Impact of the HIV epidemic on mortality trends in men 25-44 years of age in the United States [abstract No. WAO16]. V International Conference on AIDS, Montreal, Quebec, Canada, 1989.
17. Mertins SD, Cauda R. The role of polymorphonuclear leukocytes in infection by retrovirus with emphasis on the human immunodeficiency virus. Virol Immunol 1990;3:173-7.
18. Zurlo JJ, Lane HC. Other bacterial infections. In De Vita VT Jr., Hellman S, Rosenberg SA, eds. AIDS: etiology, diagnosis, treatment and prevention. Philadelphia: Lippincott-Raven, 1997:259-66.
19. Garner JS, Jarvis WR, Emoti TG. CDC definition for nosocomial infections. Am J Infect Control 1988;16:128-40.
20. Tacconelli E, Tumbarello M, Pittiruti M, et al. Central venous catheter-related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis 1997;16:203-9.
21. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR17):1-19.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 10:818-29.
23. Weber DJ, Becherer PR, Rutala WA, Samsa GP, Wilson MB, White GC. Nosocomial infection rate as a function of human immunodeficiency virus type 1 status in hemophiliacs. Am J Med 1991;91:S206-12.
24. Collignon PJ. Intravascular catheter-associated sepsis: a common problem. Med J Austr 1994;161:374-8.
25. Jarvis WR, Edwards JR, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infection Surveillance System. Am J Med 1991;91:S185-9.
26. Skoutelis AT, Murphy RL, MacDonell KB, VanRoenn JH, Sterdel CD, Phair JP. Indwelling central venous catheter infections in patients with acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1990;3:335-42.
27. Moore DA, Gazzard BG, Nelson MR. Central venous line infections in AIDS. J Infect 1997;34:35-40.
28. Jacobson MA, Ching-chi Liu R, Davies D, Cohen PT. Human immunodeficiency virus disease-related neutropenia and the risk of hospitalization for bacterial infection. Arch Intern Med 1997;157: 1825-31.
29. Ambati BK, Perlman DC, Salomon N. G-CSF/GM-CSF do not improve outcome in neutropenic patients [abstract No. 746]. 5th Conference on Retrovirus and Opportunistic Infections, 1998, Chicago.
30. Pagano L, Tacconelli E, Tumbarello M, et al. Bacteraemia in patients with haematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. Haematologica 1997; 82:415-9.
31. Gosbell IB. Central venous catheter-related sepsis: epidemiology, pathogenesis, diagnosis, treatment and prevention. Intensive Care World 1994;11:54-8.
32. Dominguez-de Villota E, Algora-Weber A, Millian I, Rubio JJ, Galdos P, Mosquera JM. Early evaluation of coagulase negative Staphylococcus in blood samples of intensive care unit patients: a clinical uncertain judgement. Intensive Care Med 1987;13:390-4.
33. Martin MA, Pfaller MA, Wenzel RP. Coagulase negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med 1989;110:9-16.
34. Tumbarello M, Tacconelli E, Lucia MB, Cauda R, Ortona L. Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. Respir Med 1996;90: 531-7.
35. Weinke T, Schiller R, Fehrenback FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992;11:985-9.
36. Raviglione MC, Marius P, Pablos-Mendez A, Battan R, Ottuso P, Taranta A. High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 1990;18:64-9.
37. Sanford JP. Pseudomonas species (including melioidosis and glanders). In Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995:2003-9.
38. Reef SE, Mayer KH. Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995;21:S99-102.
39. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14:S120-5.
40. Pittet D, Li N, Woolson RF, Wenzel RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a six year validated population based model. Clin Infect Dis 1997; 24:1068-78.
41. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
42. Spengler RF, Greenough WB. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455-58.
43. Pittet D, Li N, Wenzel RP. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality. Eur J Clin Microbiol Infect Dis 1993;12:813-19.
44. Mouton Y, Alfandari S, Valette F, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997;12:F101-5.